72 related articles for article (PubMed ID: 7524797)
1. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Malangoni MA; Song J; Herrington J; Choudhri S; Pertel P
Ann Surg; 2006 Aug; 244(2):204-11. PubMed ID: 16858182
[TBL] [Abstract][Full Text] [Related]
2. Trends in the mortality of intra-abdominal infections in adults over 25 years in the USA, 1999-2021.
Liu Y; Samaan JS; Essanaa YM; Lv F; Ji F; Samakar K; Yeo YH
Emerg Med J; 2024 Apr; 41(5):324-326. PubMed ID: 38316537
[No Abstract] [Full Text] [Related]
3. The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.
Wise R
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():97-104. PubMed ID: 8383659
[TBL] [Abstract][Full Text] [Related]
4. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
Nord CE
Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987
[TBL] [Abstract][Full Text] [Related]
5. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
Cohn SM; Lipsett PA; Buchman TG; Cheadle WG; Milsom JW; O'Marro S; Yellin AE; Jungerwirth S; Rochefort EV; Haverstock DC; Kowalsky SF
Ann Surg; 2000 Aug; 232(2):254-62. PubMed ID: 10903605
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Perry CM; Markham A
Drugs; 1999 May; 57(5):805-43. PubMed ID: 10353303
[TBL] [Abstract][Full Text] [Related]
8. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Aldridge KE
Eur J Surg Suppl; 1994; (573):31-7. PubMed ID: 7524793
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Vestweber KH; Grundel E
Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
[TBL] [Abstract][Full Text] [Related]
10. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Polk HC; Fink MP; Laverdiere M; Wilson SE; Garber GE; Barie PS; Hebert JC; Cheadle WG
Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
